Open AccessAdjuvant Therapy With Zoledronic Acid and Menopausal Status
Author(s) -
Zheng Ya Yuan,
Zhu Jian Hong
Publication year - 2013
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2013-0109
Subject(s) - medicine , adjuvant , zoledronic acid , breast cancer , oncology , adjuvant therapy , cancer
Zoledronic acid as adjuvant therapy in breast cancer patients has been shown to have a beneficial effect on OS. Adjuvant treatment with clodronate also may improve OS in patients with early breast cancer. Further study with analysis of subgroups by age or menopausal status should be performed to investigate adjuvant therapy with bisphosphonates in breast cancer patients.